MedPath

Evaluation of the effect of stromal vascular fraction (SVF) on the treatment of generalized plaque psoriasis

Not Applicable
Recruiting
Conditions
Generalized plaque psoriasis.
Psoriasis vulgaris
Registration Number
IRCT20150601022512N3
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria

Body Mass Index value of 18 to 25
generalized plaque psoriasis based on Psoriasis Area and Severity Index (PASI) of more than 10 or based on more than 10% body involvement

Exclusion Criteria

coagulation disorder
use of anticoagulation medicines
heart, lung, kidney, liver diseases and malignancy
contraindication for liposuction
active infections including HIV, HCV, HBV, HTLV1
absence of mental health

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath